


Celldex Therapeutics to Present at Oppenheimer 21st Annual Healthcare Conference November 3, 2010
NEEDHAM, Mass.--([ BUSINESS WIRE ])--Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced today that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the 21st Annual Oppenheimer & Co. Healthcare Conference at the Waldorf=Astoria Hotel in New York City on Wednesday, November 3, 2010 at 10:15 a.m. Eastern Time.
A live webcast of this presentation will be available on the aPresentationsa page of the aInvestorsa section of Celldexa™s website at [ http://www.celldextherapeutics.com ] and will be archived for 30 days following the event.
About Celldex Therapeutics, Inc.
Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit [ http://www.celldextherapeutics.com ].